Posted by Clinical Lab Products | Jul 26, 2010 | Cancer, Sepsis |
Seegene announced the availability of Magicplex Sepsis, a new multi-pathogen screening test capable of quick and accurate identification of over 90 leading sepsis-causing pathogens
Read MorePosted by Clinical Lab Products | Jul 22, 2010 | Cancer, Miscellaneous |
deCODE genetics and ARUP Laboratories today announced a partnership through which ARUP will offer deCODE’s DNA-based prostate cancer risk assessment test to its clients nationwide.
Read MorePosted by Clinical Lab Products | Jul 1, 2010 | Biochemicals & Chemical Reagents, Cancer, Prostate, Tissue Processing |
Researchers have developed a highly specific assay for the detection of ERG, a protein associated with tumor formations which is present in more than half of all prostate cancers.
Read MorePosted by Clinical Lab Products | Jun 29, 2010 | Cancer, Miscellaneous |
Aeterna Zentaris Inc announced a collaborative study with Almac’s Diagnostics division for the company’s doxorubicin luteinizing hormone-releasing hormone (LHRH) targeted conjugate compound, AEZS-108.
Read MorePosted by Clinical Lab Products | Jun 10, 2010 | Cancer, Molecular Diagnostics, Prostate |
Thomas Jefferson University in Philadelphia, PA and NuView Life Sciences have entered into an exclusive licensing agreement for advancing the development of a new molecular imaging compound which identifies genomic expressions linked to prostate cancer.
Read More